Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances

Abstract

Targeting of drugs and their carrier systems by using receptor-mediated endocytotic pathways was in its nascent stages 25 years ago. In the intervening years, an explosion of knowledge focused on design and synthesis of nanoparticulate delivery systems as well as elucidation of the cellular complexity of what was previously-termed receptor-mediated endocytosis has now created a situation when it has become possible to design and test the feasibility of delivery of highly specific nanoparticle drug carriers to specific cells and tissue. This review outlines the mechanisms governing the major modes of receptor-mediated endocytosis used in drug delivery and highlights recent approaches using these as targets for in vivo drug delivery of nanoparticles. The review also discusses some of the inherent complexity associated with the simple shift from a ligand-drug conjugate versus a ligand-nanoparticle conjugate, in terms of ligand valency and its relationship to the mode of receptor-mediated internalization.

Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines

“…[21,44,45] Active targeting is dependent on the specific ligand-receptor recognition, where nanoparticles attached with targeting moieties can bind to specific targeting cancer cells, and as a result, anchored nanoparticles enter the cells through an endocytosis pathway and release the drug within the intracellular compartments of the cells. [46] For example, compared to non-targeted magnetic nanoparticles, targeted ones with anti-HER2 monoclonal antibody specific for breast cancer cells have demonstrated 10-30-fold increased concentrations in tumor tissues. [47] Similarly, nanoparticles have also been conjugated with RGD (Arg-Gly-Asp) peptides due to their high affinity to αvβ3 integrin receptors that are highly expressed in tumor cells, thus enhancing the intratumoral drug delivery.…”

Carbon Nanotubes: a viable drug delivery platform for the treatment of cancer

“…The main characteristic of these receptors is that they must to be uniformly over-expressed in the target cells. The most studied target receptors for carcinogenic cells are transferrin, folate, surface glycoprotein receptors, and the epidermal growth factor receptor (Xu et al, 2013). When a tumor endothelium ligand is used, it is expected that the antineoplastic agent avoid the growth of new blood vessels and promote the death of the existing vessels.…”

Nano based drug delivery

“…UV-VIS spectra can be evaluated to measure reaction rates during the synthesis of dendrimers. The UV-VIS spectrum is easily recorded, however solvent selection plays an important role in correct measurement [147,148].…”